Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Celanese (CE)

Celanese Q3 adjusted EPS rises 23% to $1.65; 2026 free cash flow outlook raised

Positive Impact 4 of 5 earnings

Celanese furnished prepared remarks and a slide deck for its third quarter 2026 earnings, showing adjusted earnings per share of $1.65, up 23% from the prior year, and free cash flow of $461 million. The company raised its full-year 2026 free cash flow outlook to $750 million to $800 million and expects full-year adjusted EPS of approximately $6.00 to $6.25. Management also said a sale of a further 19% stake in the Nutrinova joint venture to Mitsui, for about $152 million, is expected to close in the coming weeks.

Key points

  • Q3 2026 adjusted EPS of $1.65, up 23% from the same period last year; free cash flow of $461 million
  • Full-year 2026 free cash flow outlook raised to $750 million to $800 million
  • Full-year 2026 adjusted EPS expected at approximately $6.00 to $6.25
  • Net debt-to-operating EBITDA was 4.9x at quarter end, with a target of about 4.7x at the end of 2026

The filing

CompanyCelanese (CE)
Form8-K, current report
Filed with the SECNov 2, 2026, 4:19 PM ET
Accession number0001306830-26-000130

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 7, 2026, 11:17 PM ET, from the text of the filing and its press-release exhibits only.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.